Carpal Tunnel Syndrome; Cts1
Description
entrapment of the median nerve in the carpal tunnel, which is formed by the flexor retinaculum and the carpal bones; this syndrome may be associated with repetitive occupational trauma, wrist injuries, amyloid neuropathies, rheumatoid arthritis, acromegaly, pregnancy, and other conditions; symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally; impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur.
Clinical Features
Phenotypes and symptoms related to Carpal Tunnel Syndrome; Cts1
- Pain
 - Peripheral neuropathy
 - Skeletal muscle atrophy
 - Scarring
 - Abnormal autonomic nervous system physiology
 - Amyloidosis
 - Constrictive median neuropathy
 - Pain insensitivity
 - Digital flexor tenosynovitis
 - Vitamin B6 deficiency
 
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Carpal Tunnel Syndrome; Cts1 Is also known as cts, amyotrophy, thenar, of carpal origin.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Carpal Tunnel Syndrome; Cts1 Recommended genes panels
| Panel Name, Specifity and genes Tested/covered | 
|---|
 	TTR.
By Molecular Diagnostic Laboratory University of Alberta (Canada). 
TTR
 
Specificity
 
100 % 
Genes
 
100 %  | 
 	Entrapment Neuropathy Evaluation.
By Athena Diagnostics Inc (United States). 
TTR, PMP22
 
Specificity
 
50 % 
Genes
 
100 %  | 
 	Amyloidosis Evaluation (TTR).
By Athena Diagnostics Inc (United States). 
TTR
 
Specificity
 
100 % 
Genes
 
100 %  | 
 	Comprehensive Cardiac Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). 
RIT1, RYR2, SCN1B, SCN2B, SCN4B, SCN5A, SGCD, SLC22A5, BRAF, SNTA1, SOS1, TAZ, TCAP, TGFB3, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TTN	, (...)
 
View the complete list with 86 more genes 
Specificity
 
1 % 
Genes
 
100 %  | 
 	Dilated & Arrhythmogenic Cardiomyopathies Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). 
RYR2, SCN5A, SGCD, TAZ, TCAP, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TTN, TTR, VCL, MYOZ2, PRDM16, ACTC1, CASQ2, LDB3, ACTN2, NEBL	, (...)
 
View the complete list with 31 more genes 
Specificity
 
2 % 
Genes
 
100 %  | 
 	Hypertrophic Cardiomyopathy Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). 
TNNC1, TNNI3, TNNT2, TPM1, TTN, TTR, MYOZ2, ACTC1, ACTN2, CSRP3, NEXN, DSG2, GLA, LAMP2, MYBPC3, MYH7, MYL2, MYL3, PKP2, PLN	, (...)
 
View the complete list with 3 more genes 
Specificity
 
5 % 
Genes
 
100 %  | 
 	Hypertrophic cardiomyopathy - full panel.
By CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario (Canada). 
TNNC1, TNNI3, TNNT2, TPM1, TTR, MYOZ2, ACTC1, CAV3, ACTN2, CSRP3, NEXN, GLA, LAMP2, MYBPC3, MYH7, MYL2, MYL3, PLN, PRKAG2
 
Specificity
 
6 % 
Genes
 
100 %  | 
 	Hypertrophic cardiomyopathy - familial variant analysis.
By CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario (Canada). 
TNNC1, TNNI3, TNNT2, TPM1, TTR, MYOZ2, ACTC1, CAV3, ACTN2, CSRP3, NEXN, GLA, LAMP2, MYBPC3, MYH7, MYL2, MYL3, PLN, PRKAG2
 
Specificity
 
6 % 
Genes
 
100 %  | 
You can get up to 176 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY DYSTONIA 28, CHILDHOOD-ONSET; DYT28 COLD-INDUCED SWEATING SYNDROME 1; CISS1 AMELOGENESIS IMPERFECTA, TYPE IV; AI4 NEPHRONOPHTHISIS 4; NPHP4
	TTR.
	Entrapment Neuropathy Evaluation.